{"id":"https://openalex.org/W2006228380","doi":"https://doi.org/10.2174/187152906777441803","title":"Cyclooxygenase-2 Inhibitors: A Painful Lesson","display_name":"Cyclooxygenase-2 Inhibitors: A Painful Lesson","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W2006228380","doi":"https://doi.org/10.2174/187152906777441803","mag":"2006228380","pmid":"https://pubmed.ncbi.nlm.nih.gov/16787194"},"language":"en","primary_location":{"id":"doi:10.2174/187152906777441803","doi":"https://doi.org/10.2174/187152906777441803","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152906777441803","pdf_url":null,"source":{"id":"https://openalex.org/S2764548042","display_name":"Cardiovascular & Haematological Disorders - Drug Targets","issn_l":"1568-0061","issn":["1568-0061","1871-529X","1875-5895","2212-4063"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular &amp; Hematological Disorders-Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006228380"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069116806","display_name":"Sandhya Sanghi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173268674","display_name":"Texas A&M University System","ror":"https://ror.org/0034eay46","country_code":"US","type":"education","lineage":["https://openalex.org/I173268674"]},{"id":"https://openalex.org/I4210116927","display_name":"Central Texas Veterans Health Care System","ror":"https://ror.org/02dcp1550","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210116927","https://openalex.org/I4210144023"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandhya Sanghi","raw_affiliation_strings":["Division of Molecular Cardiology, Cardiovascular Research Institute, The Texas A&M University System Health Science Center, College of Medicine, Scott & White, Central Texas Veterans Health Care System, Temple 76504, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Cardiology, Cardiovascular Research Institute, The Texas A&M University System Health Science Center, College of Medicine, Scott & White, Central Texas Veterans Health Care System, Temple 76504, USA","institution_ids":["https://openalex.org/I173268674","https://openalex.org/I4210116927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005946919","display_name":"Eric J. MacLaughlin","orcid":"https://orcid.org/0000-0002-1460-445X","observed_orcids":["https://orcid.org/0000-0002-1460-445X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric MacLaughlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108263657","display_name":"Coty W. Jewell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Coty Jewell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036863767","display_name":"Sheldon Chaffer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sheldon Chaffer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Naus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Naus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085430386","display_name":"Linley E. Watson","orcid":"https://orcid.org/0009-0002-7882-6294","observed_orcids":["https://orcid.org/0009-0002-7882-6294"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linley Watson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020208896","display_name":"David E. Dostal","orcid":"https://orcid.org/0000-0002-1180-1546","observed_orcids":["https://orcid.org/0000-0002-1180-1546"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Dostal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8118,"has_fulltext":false,"cited_by_count":75,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95113208,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"2","first_page":"83","last_page":"98"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9150000214576721},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8679999709129333},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.777999997138977},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.6679999828338623},{"id":"https://openalex.org/keywords/prostacyclin","display_name":"prostacyclin","score":0.984000027179718},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6460000276565552},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9558285474777222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9126012921333313},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7937608957290649},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.7494947910308838},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6421537399291992},{"id":"https://openalex.org/C2779528491","wikidata":"https://www.wikidata.org/wiki/Q347613","display_name":"Valdecoxib","level":5,"score":0.5936248898506165},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.5872523188591003},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5348039865493774},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4850289225578308},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4849146008491516},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.4813569188117981},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.4622696340084076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35171282291412354},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.09947213530540466},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003257","descriptor_name":"Consumer Product Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187152906777441803","doi":"https://doi.org/10.2174/187152906777441803","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152906777441803","pdf_url":null,"source":{"id":"https://openalex.org/S2764548042","display_name":"Cardiovascular & Haematological Disorders - Drug Targets","issn_l":"1568-0061","issn":["1568-0061","1871-529X","1875-5895","2212-4063"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular &amp; Hematological Disorders-Drug Targets","raw_type":"journal-article"},{"id":"pmid:16787194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16787194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular & hematological disorders drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7032346748","display_name":"Mechanical Signaling Mechanisms in Cardiac Tissue","funder_award_id":"R01HL068838","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":192,"referenced_works":["https://openalex.org/W24263518","https://openalex.org/W97893626","https://openalex.org/W107715711","https://openalex.org/W146953779","https://openalex.org/W568063224","https://openalex.org/W1485442945","https://openalex.org/W1489584806","https://openalex.org/W1506887248","https://openalex.org/W1509158050","https://openalex.org/W1511836437","https://openalex.org/W1548653314","https://openalex.org/W1555321622","https://openalex.org/W1584314654","https://openalex.org/W1585542836","https://openalex.org/W1587123510","https://openalex.org/W1612985315","https://openalex.org/W1648593433","https://openalex.org/W1748398046","https://openalex.org/W1766737321","https://openalex.org/W1828786787","https://openalex.org/W1831046814","https://openalex.org/W1891796405","https://openalex.org/W1922681024","https://openalex.org/W1964797510","https://openalex.org/W1969816132","https://openalex.org/W1974026314","https://openalex.org/W1974995633","https://openalex.org/W1976019172","https://openalex.org/W1976943402","https://openalex.org/W1977537469","https://openalex.org/W1978213781","https://openalex.org/W1982163998","https://openalex.org/W1982512584","https://openalex.org/W1982584793","https://openalex.org/W1985844039","https://openalex.org/W1986619381","https://openalex.org/W1987212025","https://openalex.org/W1987578146","https://openalex.org/W1988528060","https://openalex.org/W1990030459","https://openalex.org/W1990167955","https://openalex.org/W1991659746","https://openalex.org/W1992309009","https://openalex.org/W1993966022","https://openalex.org/W1994187153","https://openalex.org/W1995425192","https://openalex.org/W1997208118","https://openalex.org/W1997861448","https://openalex.org/W1998167638","https://openalex.org/W1999208756","https://openalex.org/W2001162433","https://openalex.org/W2001214229","https://openalex.org/W2001350224","https://openalex.org/W2002384956","https://openalex.org/W2003016773","https://openalex.org/W2004371769","https://openalex.org/W2004890666","https://openalex.org/W2004916700","https://openalex.org/W2008015660","https://openalex.org/W2008424322","https://openalex.org/W2010008459","https://openalex.org/W2011566658","https://openalex.org/W2011861566","https://openalex.org/W2012525268","https://openalex.org/W2018630281","https://openalex.org/W2018716226","https://openalex.org/W2020563114","https://openalex.org/W2021918003","https://openalex.org/W2023243818","https://openalex.org/W2023887529","https://openalex.org/W2024289681","https://openalex.org/W2025597633","https://openalex.org/W2026847539","https://openalex.org/W2030768867","https://openalex.org/W2032428750","https://openalex.org/W2032771313","https://openalex.org/W2033456567","https://openalex.org/W2033745068","https://openalex.org/W2037107042","https://openalex.org/W2037857918","https://openalex.org/W2038197749","https://openalex.org/W2039074779","https://openalex.org/W2039337821","https://openalex.org/W2042928324","https://openalex.org/W2047114067","https://openalex.org/W2051686420","https://openalex.org/W2051708832","https://openalex.org/W2052364512","https://openalex.org/W2054998837","https://openalex.org/W2055691692","https://openalex.org/W2057685090","https://openalex.org/W2059860834","https://openalex.org/W2061293248","https://openalex.org/W2061857216","https://openalex.org/W2062155948","https://openalex.org/W2063841251","https://openalex.org/W2064663457","https://openalex.org/W2070944916","https://openalex.org/W2072259978","https://openalex.org/W2073413820","https://openalex.org/W2075560619","https://openalex.org/W2076510126","https://openalex.org/W2078825325","https://openalex.org/W2080605373","https://openalex.org/W2081597511","https://openalex.org/W2081839293","https://openalex.org/W2082001748","https://openalex.org/W2083651943","https://openalex.org/W2083923976","https://openalex.org/W2084120431","https://openalex.org/W2084544703","https://openalex.org/W2084647545","https://openalex.org/W2085270986","https://openalex.org/W2088179332","https://openalex.org/W2088263896","https://openalex.org/W2088326857","https://openalex.org/W2089638313","https://openalex.org/W2092533392","https://openalex.org/W2094584843","https://openalex.org/W2096198355","https://openalex.org/W2097716284","https://openalex.org/W2099077008","https://openalex.org/W2099133407","https://openalex.org/W2099438717","https://openalex.org/W2099902447","https://openalex.org/W2102368544","https://openalex.org/W2102649280","https://openalex.org/W2103610125","https://openalex.org/W2104379105","https://openalex.org/W2105605377","https://openalex.org/W2106015379","https://openalex.org/W2106319388","https://openalex.org/W2108383143","https://openalex.org/W2111208488","https://openalex.org/W2112336272","https://openalex.org/W2113745276","https://openalex.org/W2113892902","https://openalex.org/W2114014099","https://openalex.org/W2117858791","https://openalex.org/W2119671318","https://openalex.org/W2122067835","https://openalex.org/W2123151902","https://openalex.org/W2127607312","https://openalex.org/W2128100003","https://openalex.org/W2128181849","https://openalex.org/W2129960830","https://openalex.org/W2134732424","https://openalex.org/W2134761503","https://openalex.org/W2137958975","https://openalex.org/W2139510950","https://openalex.org/W2139776244","https://openalex.org/W2140631527","https://openalex.org/W2140873821","https://openalex.org/W2142699862","https://openalex.org/W2142942047","https://openalex.org/W2143378100","https://openalex.org/W2144389717","https://openalex.org/W2145149010","https://openalex.org/W2146605723","https://openalex.org/W2147411733","https://openalex.org/W2148089655","https://openalex.org/W2148122132","https://openalex.org/W2148907720","https://openalex.org/W2149233326","https://openalex.org/W2150336097","https://openalex.org/W2150479709","https://openalex.org/W2151110872","https://openalex.org/W2153853877","https://openalex.org/W2155820793","https://openalex.org/W2157163846","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2162517111","https://openalex.org/W2163756514","https://openalex.org/W2164597973","https://openalex.org/W2166762863","https://openalex.org/W2166867110","https://openalex.org/W2172254808","https://openalex.org/W2173115825","https://openalex.org/W2184642557","https://openalex.org/W2275889607","https://openalex.org/W2287187947","https://openalex.org/W2301334316","https://openalex.org/W2312652235","https://openalex.org/W2330496155","https://openalex.org/W2336169581","https://openalex.org/W2336643794","https://openalex.org/W2394843245","https://openalex.org/W2413774443","https://openalex.org/W2505628163","https://openalex.org/W3184707974","https://openalex.org/W4237306139"],"related_works":["https://openalex.org/W2037967805","https://openalex.org/W2160378840","https://openalex.org/W2021218503","https://openalex.org/W2115693120","https://openalex.org/W2132787082","https://openalex.org/W2084447650","https://openalex.org/W2031340028","https://openalex.org/W2037678543","https://openalex.org/W2009486610","https://openalex.org/W4280569121"],"abstract_inverted_index":{"Non-steroidal":[0],"anti-inflammatory":[1],"drugs":[2],"(NSAIDs)":[3],"represent":[4],"a":[5,136,217],"clinically":[6],"important":[7,229],"class":[8],"of":[9,17,33,41,52,94,108,110,116,147,164,183,190,202,252,277],"agents.":[10],"NSAIDs":[11],"are":[12,56,226],"commonly":[13,79],"used":[14],"in":[15,38,139,166,209,214,235,240,271],"treatment":[16],"conditions":[18],"such":[19,69],"as":[20,70,82],"headache,":[21],"fever,":[22],"inflammation":[23],"and":[24,45,47,74,185,213,224,249,260,269,274],"joint":[25],"pain.":[26],"Complications":[27],"often":[28],"arise":[29],"from":[30,193],"chronic":[31],"use":[32],"NSAIDs.":[34,53],"Gastrointestinal":[35,150],"(GI)":[36],"toxicity":[37],"the":[39,106,148,194,227],"form":[40],"gastritis,":[42],"peptic":[43],"erosions":[44],"ulcerations":[46],"GI":[48],"bleeds":[49],"limit":[50],"usage":[51,163],"These":[54],"toxicities":[55],"thought":[57],"to":[58,61,81,86,121,188,216,245],"be":[59],"due":[60],"cyclooxygenase":[62],"(COX)-1":[63],"blockade.":[64],"COX-1":[65,95,268],"generates":[66],"cytoprotective":[67],"prostanoids":[68,89,113,265],"prostaglandin":[71],"(PG)":[72],"E2":[73],"prostacyclin":[75],"(PGI2).":[76],"COX-2":[77,204,206,270],"inhibitors,":[78],"referred":[80],"coxibs,":[83],"were":[84],"developed":[85],"inhibit":[87],"inflammatory":[88],"without":[90,114],"interfering":[91],"with":[92,160,168,264],"production":[93],"prostanoids.":[96,231],"Concerns":[97],"over":[98],"cardiovascular":[99,123,140,158,181],"safety,":[100],"however,":[101],"have":[102],"evolved":[103],"based":[104],"on":[105,175],"concept":[107],"inhibition":[109,115,233,238],"COX-2-derived":[111],"endothelial":[112],"platelet":[117],"thromboxane":[118],"A2,":[119],"leading":[120],"increased":[122,157],"risk.":[124],"The":[125,171],"Celecoxib":[126],"Long-Term":[127],"Arthritis":[128],"Safety":[129],"Study":[130],"(CLASS)":[131],"trial":[132,178],"did":[133],"not":[134],"show":[135],"significant":[137],"increase":[138],"risk":[141,159],"for":[142],"celecoxib":[143],"(Celebrex),":[144],"but":[145],"results":[146,234,239],"Vioxx":[149,176],"Outcomes":[151],"Research":[152],"(VIGOR)":[153],"study":[154],"showed":[155],"an":[156],"long-term":[161],"daily":[162],"rofecoxib":[165,184],"patients":[167],"rheumatoid":[169],"arthritis.":[170],"Adenomatous":[172],"Poly":[173],"Prevention":[174],"(APPROVe)":[177],"further":[179],"evaluated":[180],"effects":[182,262],"recently":[186],"led":[187],"removal":[189],"this":[191],"drug":[192],"marketplace.":[195],"Coxibs":[196],"affect":[197],"renal":[198,230],"function":[199],"via":[200],"blockade":[201,276],"normal":[203],"functions.":[205],"expression":[207],"increases":[208],"high":[210],"renin":[211],"states":[212],"response":[215],"high-sodium":[218],"diet":[219],"or":[220],"water":[221],"deprivation.":[222],"PGI2":[223,232],"PGE2":[225,237],"most":[228],"hyperkalemia.":[236],"sodium":[241],"retention,":[242],"which":[243],"leads":[244],"hypertension,":[246],"peripheral":[247],"edema":[248],"potentially":[250],"exacerbation":[251],"heart":[253],"failure.":[254],"This":[255],"review":[256],"article":[257],"discusses":[258],"beneficial":[259],"deleterious":[261],"associated":[263],"produced":[266],"by":[267],"various":[272],"organs":[273],"how":[275],"these":[278],"products":[279],"translates":[280],"into":[281],"clinical":[282],"medicine.":[283]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006228380","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
